Cipher Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CIPHER, and what generic alternatives to CIPHER drugs are available?
CIPHER has three approved drugs.
There is one US patent protecting CIPHER drugs.
Drugs and US Patents for Cipher
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cipher Pharms Inc | CONZIP | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370-004 | Aug 1, 2011 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Cipher Pharms Inc | CONZIP | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370-002 | May 7, 2010 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Cipher | NATROBA | spinosad | SUSPENSION;TOPICAL | 022408-001 | Jan 18, 2011 | RX | Yes | Yes | 9,895,388 | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Cipher
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cipher Pharms Inc | CONZIP | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370-002 | May 7, 2010 | 7,858,118 | ⤷ Subscribe |
Cipher Pharms Inc | LIPOFEN | fenofibrate | CAPSULE;ORAL | 021612-003 | Jan 11, 2006 | 5,545,628 | ⤷ Subscribe |
Cipher Pharms Inc | CONZIP | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370-001 | May 7, 2010 | 7,858,118 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.